| mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-05 |